- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02089191
Tear Film Stability of DAILIES® AquaComfort Plus® Contact Lenses vs. MyDay® Daily Disposable Contact Lenses
April 30, 2015 updated by: Alcon Research
Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses Using Ring Mire Projection
The purpose of this study is to evaluate tear film stability of DAILIES® AquaComfort Plus® (DACP) compared to MyDay® after 12 hours of lens wear.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jena, Germany
- Alcon Investigative Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 44 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must sign an Informed Consent form;
- Adapted, current soft contact lens wearer;
- Required contact lens prescription within the power range specified in the protocol (+6.00 to -10.00 diopters (D));
- Cylinder ≤ -1.00 D in both eyes at Visit 1;
- Vision correctable to 0.1 logarithm of the Minimum Angle of Resolution (logMAR) or better in each eye at distance with pre-study lenses at Visit 1;
- Willing to wear study lenses up to 12 hours and attend all study visits;
- Able to be successfully fitted with study lenses;
- Unstable tear film with a NIK-BUT value below 13 seconds in either eye without lenses;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Any ocular infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
- Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator;
- Use of artificial tears and rewetting drops during the study;
- Monocular (only 1 eye with functional vision) or fit with only 1 lens;
- Any abnormal ocular condition observed during Visit 1;
- History of herpetic keratitis, ocular surgery, or irregular cornea;
- Pregnant or lactating;
- Participation in any clinical study within 30 days of Visit 1;
- Current MyDay® or DAILIES® AquaComfort Plus® lens wearer;
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: DACP/MyDay
Nelfilcon A contact lenses worn in Period 1, with stenfilcon A contact lenses in Period 2. Each product worn bilaterally for 12 hours over 1 day.
|
Other Names:
Other Names:
|
Other: MyDay/DACP
Stenfilcon A contact lenses worn in Period 1, with nelfilcon A contact lenses in Period 2. Each product worn bilaterally for 12 hours over 1 day.
|
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Time Post-blink to 15% Distortion of the Projected Rings After 12 Hours of Lens Wear
Time Frame: Day 1, Hour 12, each period
|
The participant blinked twice, then kept eye open.
Circular images were projected onto tear film layer located on the surface of the contact lens.
Measuring software automatically detected areas where the tear film destabilized after the blink.
The time to 15% destabilization of the tear film was calculated.
A longer time indicates a more stable tear film.
The right eye was evaluated.
|
Day 1, Hour 12, each period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Speed of Tear Film Break-up at 15 Seconds Post-blink After 12 Hours of Lens Wear
Time Frame: Hour 12
|
The participant blinked twice, then kept eye open.
Circular images were projected onto tear film layer located on the surface of the contact lens.
Measuring software automatically detected areas where the tear film destabilized after the blink.
The slope of the regression line (distorted areas vs. time) was calculated.
A slower speed (higher number) indicates a more stable tear film.
The right eye was evaluated.
|
Hour 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Global Medical Affairs, Clinical Manager, Vision Care, Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
March 14, 2014
First Submitted That Met QC Criteria
March 14, 2014
First Posted (Estimate)
March 17, 2014
Study Record Updates
Last Update Posted (Estimate)
May 15, 2015
Last Update Submitted That Met QC Criteria
April 30, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-14-006
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Abbott Medical OpticsCompletedStable Myopic Refractive Error, With or Without AstigmatismUnited States
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
Clinical Trials on Nelfilcon A contact lenses
-
Alcon ResearchCompletedRefractive Error | Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive ErrorsUnited Kingdom
-
CIBA VISIONCompletedRefractive Error | Astigmatism | Myopia
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedMyopia | Dry Eye Syndrome
-
Alcon ResearchCompletedRefractive Error | Myopia | Hyperopia
-
Alcon ResearchCompletedRefractive Error | Myopia | Myopic Astigmatism
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive Errors | PresbyopiaUnited States, Canada, United Kingdom